South Africa:1 July 2021 (TDI): On 30 June, The World Bank and E3 governments have announced to fund the production of COVID-19 vaccines in South Africa.
French Ambassador to South Africa, Lesotho, and Malawi Mr. Aurelien Lechevallier said that “France is proud to be part of this effort and we will support African people to fight with the pandemic.”
A financing package for the production of the Johnson&Johnson vaccine is announced in South Africa.
The deal is of 600 million euros ($712 million) which will support Aspen Pharmacare Holdings Ltd to produce 500 million doses of the shots through 2022. Almost 30 million of the doses will be produced for use in South Africa in 2021, and out of a total of 250 million doses due by the end of 2022.